Literature DB >> 6217901

Characterization of fibroblast proliferation factors elaborated by antigen- and mitogen-stimulated guinea pig lymph node cells: differentiation from lymphocyte-derived chemotactic factor for fibroblasts, lymphocyte mitogenic factor, and interleukin 1.

A E Postlethwaite, A H Kang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6217901     DOI: 10.1016/0008-8749(82)90445-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  10 in total

Review 1.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 2.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985

3.  Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis.

Authors:  N K Harrison; R J McAnulty; P L Haslam; C M Black; G J Laurent
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

4.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

5.  Macrophage-derived growth factor for osteoblast-like cells and chondrocytes.

Authors:  L Rifas; V Shen; K Mitchell; W A Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Interleukin-1 production by mononuclear cells from patients with scleroderma.

Authors:  C I Sandborg; M A Berman; B S Andrews; G J Friou
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

7.  A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin 1 or a related protein.

Authors:  H J Ristow
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Cerebrospinal fluid interleukin 1 like activity during chronic relapsing experimental allergic encephalomyelitis.

Authors:  J A Symons; R V Bundick; A J Suckling; M G Rumsby
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

9.  Studies of an interleukin 1 inhibitor: characterization and clinical significance.

Authors:  M A Berman; C I Sandborg; B S Calabia; B S Andrews; G J Friou
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  Mode of fibroblast growth enhancement by human interleukin-1.

Authors:  J P Singh; L D Adams; P D Bonin
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.